News releases from the National Institutes of Health (NIH)
Updated: 16 hours 54 min ago
Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study.
More than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2.
The trial is now enrolling hospitalized adults with COVID-19 in the United States.
For the millions of people living with a rare disease, the novel coronavirus disease COVID-19 presents unique challenges.
Previous research has shown that young children who have a sibling with ASD are at a higher risk for also being diagnosed with the condition.
NIH-funded study highlights importance of emergency department-based interventions for mitigating suicide risk.
NIH-funded study may have implications for pediatric cancer treatment.
Asthma is a chronic lung disease that causes periods of wheezing, chest tightness, shortness of breath, and coughing.
NIH-funded study also will ascertain percentage of infected children who develop COVID-19.
Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo.
Initiative aims to speed delivery of accurate, easy-to-use, scalable tests to all Americans.
Suggests that targeting sleep may help prevent diabetes and improve treatment.
NIH-funded study finds very low doses effective for treating retinopathy of prematurity.
Urgent public health measures are needed to control the spread of the novel coronavirus.
“Living document” expected to be updated often as new clinical data accrue.
Findings point to targeting epigenome as a potential therapeutic strategy.
Behavioral inhibition in infancy associated with introversion and internalizing psychopathology in adulthood.
Study supports clinical testing under way across U.S.
Vaccine neutralizes multiple MERS-CoV strains.
Health agencies, leading pharmaceutical companies to join forces to accelerate pandemic response.